183 related articles for article (PubMed ID: 25295271)
1. KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis.
Woo SR; Ham Y; Kang W; Yang H; Kim S; Jin J; Joo KM; Nam DH
Biomed Res Int; 2014; 2014():747415. PubMed ID: 25295271
[TBL] [Abstract][Full Text] [Related]
2. KML001 displays vascular disrupting properties and irinotecan combined antitumor activities in a murine tumor model.
Moon CH; Lee SJ; Lee HY; Lee JC; Cha H; Cho WJ; Park JW; Park HJ; Seo J; Lee YH; Song HT; Min YJ
PLoS One; 2013; 8(1):e53900. PubMed ID: 23326531
[TBL] [Abstract][Full Text] [Related]
3. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo study.
Yoon JS; Hwang DW; Kim ES; Kim JS; Kim S; Chung HJ; Lee SK; Yi JH; Uhm J; Won YW; Park BB; Choi JH; Lee YY
Invest New Drugs; 2016 Feb; 34(1):1-14. PubMed ID: 26581399
[TBL] [Abstract][Full Text] [Related]
5. Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities.
Lee EJ; Sung JY; Koo KH; Park JB; Kim DH; Shim J; Lee CH; Park J; Kim YN
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256086
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular Dysfunctions.
Cao D; Zhao J; Nguyan LN; Nguyen LNT; Khanal S; Dang X; Schank M; Chand Thakuri BK; Wu XY; Morrison ZD; El Gazzar M; Zou Y; Ning S; Wang L; Moorman JP; Yao ZQ
Front Immunol; 2019; 10():1152. PubMed ID: 31191531
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of arsenic trioxide, vismodegib and temozolomide on glioblastoma.
Bureta C; Saitoh Y; Tokumoto H; Sasaki H; Maeda S; Nagano S; Komiya S; Taniguchi N; Setoguchi T
Oncol Rep; 2019 Jun; 41(6):3404-3412. PubMed ID: 31002372
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms.
Chakravarti A; Erkkinen MG; Nestler U; Stupp R; Mehta M; Aldape K; Gilbert MR; Black PM; Loeffler JS
Clin Cancer Res; 2006 Aug; 12(15):4738-46. PubMed ID: 16899625
[TBL] [Abstract][Full Text] [Related]
9. MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo.
Liu T; Li A; Xu Y; Xin Y
Cancer Med; 2019 Feb; 8(2):751-760. PubMed ID: 30656846
[TBL] [Abstract][Full Text] [Related]
10. Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.
Rubner Y; Muth C; Strnad A; Derer A; Sieber R; Buslei R; Frey B; Fietkau R; Gaipl US
Radiat Oncol; 2014 Mar; 9(1):89. PubMed ID: 24678590
[TBL] [Abstract][Full Text] [Related]
11. Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling.
Yin H; Zhou Y; Wen C; Zhou C; Zhang W; Hu X; Wang L; You C; Shao J
Oncol Rep; 2014 Oct; 32(4):1610-6. PubMed ID: 25050915
[TBL] [Abstract][Full Text] [Related]
12. miR‑146b‑5p suppresses glioblastoma cell resistance to temozolomide through targeting TRAF6.
Qian Z; Zhou S; Zhou Z; Yang X; Que S; Lan J; Qiu Y; Lin Y
Oncol Rep; 2017 Nov; 38(5):2941-2950. PubMed ID: 29048680
[TBL] [Abstract][Full Text] [Related]
13. KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway.
You D; Kim Y; Jang MJ; Lee C; Jeong IG; Cho YM; Hwang JJ; Hong JH; Ahn H; Kim CS
PLoS One; 2015; 10(9):e0137589. PubMed ID: 26352139
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.
Yamini B; Yu X; Gillespie GY; Kufe DW; Weichselbaum RR
Cancer Res; 2004 Sep; 64(18):6381-4. PubMed ID: 15374943
[TBL] [Abstract][Full Text] [Related]
15. Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines.
Clarke MJ; Mulligan EA; Grogan PT; Mladek AC; Carlson BL; Schroeder MA; Curtin NJ; Lou Z; Decker PA; Wu W; Plummer ER; Sarkaria JN
Mol Cancer Ther; 2009 Feb; 8(2):407-14. PubMed ID: 19174557
[TBL] [Abstract][Full Text] [Related]
16. Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.
Castro-Gamero AM; Borges KS; Moreno DA; Suazo VK; Fujinami MM; de Paula Gomes Queiroz R; de Oliveira HF; Carlotti CG; Scrideli CA; Tone LG
Invest New Drugs; 2013 Aug; 31(4):858-70. PubMed ID: 23299390
[TBL] [Abstract][Full Text] [Related]
17. Antitumoral effect of arsenic compound, sodium metaarsenite (KML001), on multiple myeloma cells.
Kim SJ; Kim ES; Kim S; Uhm J; Won YW; Park BB; Choi JH; Lee YY
Int J Oncol; 2017 Dec; 51(6):1739-1746. PubMed ID: 29039521
[TBL] [Abstract][Full Text] [Related]
18. Probing the Oncolytic and Chemosensitizing Effects of Dihydrotanshinone in an
Kumar V; Radin D; Leonardi D
Anticancer Res; 2017 Nov; 37(11):6025-6030. PubMed ID: 29061781
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of combined temozolomide and radiotherapy using X rays and high-linear energy transfer radiation for glioblastoma.
Barazzuol L; Jena R; Burnet NG; Jeynes JC; Merchant MJ; Kirkby KJ; Kirkby NF
Radiat Res; 2012 May; 177(5):651-62. PubMed ID: 22468703
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.
Golubovskaya VM; Huang G; Ho B; Yemma M; Morrison CD; Lee J; Eliceiri BP; Cance WG
Mol Cancer Ther; 2013 Feb; 12(2):162-72. PubMed ID: 23243059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]